Published in Transplantation on September 27, 2005
Renal transplantation with kidneys affected by tumours. Int J Nephrol (2011) 0.81
Nephron-sparing surgery for adenocarcinoma in a renal allograft. Case Rep Urol (2012) 0.75
Post-renal Transplantation de novo Renal Cell Carcinoma in a Middle-aged Man. Int J Organ Transplant Med (2016) 0.75
Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol (2009) 3.35
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol (2005) 2.68
Identification of alternative splicing markers for breast cancer. Cancer Res (2008) 2.51
Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up. Eur Urol (2012) 2.43
The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. BJU Int (2005) 2.31
Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? Medicine (Baltimore) (2015) 1.45
Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ). Eur Urol (2006) 1.43
[Role of endoscopy in the management of upper urinary tract tumors]. Prog Urol (2006) 1.39
Impact on active scope deflection and irrigation flow of all endoscopic working tools during flexible ureteroscopy. Eur Urol (2004) 1.35
The AdVance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months. Eur Urol (2009) 1.32
Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int (2006) 1.26
Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators. Mol Cell Biol (2011) 1.24
RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol Cell Biol (2012) 1.22
Technique and complications of transurethral surgery for bladder tumours. BJU Int (2004) 1.19
Late metastasis of renal cell carcinoma to the submaxillary gland 10 years after radical nephrectomy. Int J Urol (2006) 1.19
Alternative splicing of SYK regulates mitosis and cell survival. Nat Struct Mol Biol (2011) 1.17
New-generation flexible ureterorenoscopes are more durable than previous ones. Urology (2006) 1.17
Midterm prospective evaluation of TVT-Secur reveals high failure rate. Eur Urol (2010) 1.13
Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors. BJU Int (2010) 1.09
Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int (2005) 1.06
PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. Hum Mol Genet (2011) 1.04
Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology (2006) 1.04
MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Nat Commun (2013) 1.03
Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol (2006) 1.02
Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology (2006) 1.00
Laparoscopic excision of seminal vesicle cyst revealed by obstruction urinary symptoms. Int J Urol (2006) 0.98
Overactive bladder: Is there a link to the metabolic syndrome in men? Neurourol Urodyn (2010) 0.98
The safety of the inside-out transobturator approach for transvaginal tape (TVT-O) treatment in stress urinary incontinence: French registry data on 984 women. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.94
Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med (2002) 0.92
Can ureteral stent encrustation analysis predict urinary stone composition? Urology (2005) 0.87
Superficial bladder tumors. Eur Urol (2002) 0.87
Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.86
Modeling RNA tertiary structure motifs by graph-grammars. Nucleic Acids Res (2007) 0.86
Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinoma. Mol Carcinog (2010) 0.86
Tumor microenvironment-associated modifications of alternative splicing. RNA (2013) 0.85
A critical review of diagnostic criteria for evaluating patients with symptomatic stress urinary incontinence. BJU Int (2005) 0.84
Redirecting splicing with bifunctional oligonucleotides. Nucleic Acids Res (2013) 0.84
[Clinical usefulness of positron emission tomography in prostate cancer]. Presse Med (2007) 0.84
Clinical significance of routine urinary bacterial culture after transurethral surgery: results of a prospective multicenter study. Urology (2012) 0.83
Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J (2010) 0.82
[Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial]. Prog Urol (2002) 0.81
[Kidney tumors]. Prog Urol (2004) 0.80
Ajust single incision transobturator sling procedure for stress urinary incontinence: results after 1-year follow-up. Int Urogynecol J (2012) 0.80
Endoscopic lithotripsy and the FREDDY laser: initial experience. J Endourol (2006) 0.80
[Bladder perforation during transurethral resection of bladder tumour: a review]. Prog Urol (2007) 0.80
[Medium-term results of grade 3 and 4 cystocele repair by porcine xenograft matrix (pelvicol)]. Prog Urol (2007) 0.80
[How to avoid accumulation of stone fragments in the lower calix during flexible ureterorenoscopy]. Prog Urol (2005) 0.78
[Study of the safety of double J ureteric stents]. Prog Urol (2006) 0.78
[How to identify the neck of a caliceal diverticulum in flexible ureterorenoscopy]. Prog Urol (2005) 0.78
Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection. J Urol (2002) 0.76
[Cystectomy with preservation of the prostate in the treatment of bladder tumours: anatomical basis, surgical techniques, indications and results]. Prog Urol (2003) 0.76
Bladder function after radical hysterectomy for cervical cancer. Neurourol Urodyn (2014) 0.76
Evidence of occult dysautonomia in Fowler's syndrome: alteration of cardiovascular autonomic function tests in female patients presenting with urinary retention. BJU Int (2006) 0.75
Rapidly progressive kidney failure induced by fungal mycelia obstructing indwelling ureteral stents. BMJ Case Rep (2012) 0.75
Retrograde Approach to a Diverticular Kidney Stone through a Vesicoureteral Cohen's Reimplantation: A Novel Surgical Technique. Case Rep Urol (2013) 0.75
T1G3 bladder cancer: conservative management or cystectomy? Eur Urol (2004) 0.75
Mini-slings for female stress urinary incontinence: not yet at the age of reason. Eur Urol (2011) 0.75
Long-term follow-up after regenerative therapy of the urethral sphincter for female stress urinary incontinence. Eur Urol (2013) 0.75
[The p53 gene]. Prog Urol (2005) 0.75
[Pseudo-tumor form of bladder scleroderma: unusual cause of hematuria]. Prog Urol (2002) 0.75
[Comparative study of two latest generation flexible ureterorenoscopes]. Prog Urol (2005) 0.75
[Laparoscopic nephrectomy for benign kidney disease. Review of a 12-year experience and review of the literature]. Prog Urol (2004) 0.75
[Infertility and testicular seminoma]. Presse Med (2007) 0.75
[Multiple endocrine neoplasia type 1: a possible cause of severe and recurrent urolithiasis]. Prog Urol (2006) 0.75
[Inferior calyx stone and flexible ureterorenoscopy to mobilize the stone before fragmentation]. Prog Urol (2006) 0.75
[Vitamin C and stone risk. Review of the literature]. Prog Urol (2003) 0.75
Pyonephrosis Caused by Salmonella Typhi: A Case Report. Urol Int (2014) 0.75
[Flexible double active deflection ureterorenoscopy]. Prog Urol (2003) 0.75
[Giant parathyroid adenoma causing early recurrence of renal stones]. Prog Urol (2004) 0.75
[Management of dog bite trauma of the external genital organs]. Prog Urol (2004) 0.75
[Value of infrared spectrophotometry morpho-constitutional analysis of double J stent encrustations for indirect determination of urinary stone composition]. Prog Urol (2005) 0.75
[Endoscopic lithotripsy and FREDDY laser technology. Initial experience]. Prog Urol (2005) 0.75
[Evaluation of visual stimulation combined with intracavernous injections for the treatment of severe erectile dysfunction]. Prog Urol (2007) 0.75
[Spontaneous renal haematoma: diagnostic and therapeutic approach in 7 cases]. Prog Urol (2004) 0.75